Psychedelics for Depression & Anxiety

4 million people suffer from depression & anxiety in the UK. Research has shown the potential of psilocybin to treat these conditions, yet it is being hindered by the restrictive Schedule 1 status of the substance.

By rescheduling psilocybin from Schedule 1 to Schedule 2, research would become faster and cheaper, and doctors would be able to start prescribing the substance when they see fit.

Use this tool to ask your MP to sign the Psychedelic Society's petition to reschedule psilocybin from Schedule 1 to Schedule 2. Enter your postcode to get started.

Powered by Writerep. PPC data provided by Democracy Club